Potential contributors to variable penetrance of NOTCH3 p.Arg1231Cys Variant

Sep 2

Written by Fanny Elahi

Rapid plaque clearance with anti-amyloid therapy for Alzheimer’s disease: in consideration of donanemab treatment duration from real-world cases

Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer’s Disease from Phase 3 and Phase 2 Trials